INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON

干扰素对人类癌基因表达的抑制

基本信息

项目摘要

Prolonged alpha/beta interferon (IFN-alpha/beta) or recombinant IFN-beta treatment of RS485, NIH 3T3 cells transformed by a long terminal repeat-activated Ha-ras proto-oncogene resulted in revertants that maintain a non-transformed phenotype long after IFN treatment had been discontinued. Cloned persistent revertants (PRs) produced large amounts of the ras-encoded p21 and were refractile to transformation by EJras DNA and by transforming retroviruses which carried the v-Ha-ras, v-Ki-ras, v-abl, or v-fes oncogene. Transient treatment either in vitro or in vivo with cytidine analogs that alter gene expression by inhibiting DNA methylation resulted in transformation of PR, but not of NIH 3T3 cells. We wish to study the mechanisms involved in this persistent reversion. We hope to demonstrate altered patterns of gene expression in the persistent revertants by identifying in cDNA libraries cell messages that are differentially expressed in PRs and RS485s. The potential of these cDNAs to affect the phenotype of RS485 or persistent revertant cells will be evaluated by transfecting these cells with constructs that will allow the over-expression of either message or anti-sense message. Genomic clones of differentially expressed gene will also be obtained and the flanking regulatory regions analyzed. We also wish to investigate the possible roles of co-transforming oncogenes, endogenous IFN production, and DNA methylation of regulatory sites in the phenomenon of persistent reversion, and to study further the resistance of PRs to re-transformation by various viral and cellular oncogenes.
延长α / β干扰素(ifn - α / β)或重组

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT M FRIEDMAN其他文献

ROBERT M FRIEDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT M FRIEDMAN', 18)}}的其他基金

OBJECT ORIENTATION IN THE SOMATOSENSORY CORTEX
体感皮层的物体定向
  • 批准号:
    2685635
  • 财政年份:
    1998
  • 资助金额:
    $ 9.15万
  • 项目类别:
OBJECT ORIENTATION IN THE SOMATOSENSORY CORTEX
体感皮层的物体定向
  • 批准号:
    2393954
  • 财政年份:
    1997
  • 资助金额:
    $ 9.15万
  • 项目类别:
INFECTIOUS ETIOLOGY OF AIDS IN HEMOPHILIACS
血友病患者艾滋病的感染病因
  • 批准号:
    3546562
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON
干扰素对人类癌基因表达的抑制
  • 批准号:
    3175183
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
A MECHANISM OF INTERFERON ACTION
干扰素的作用机制
  • 批准号:
    3177699
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON
干扰素对人类癌基因表达的抑制
  • 批准号:
    6632930
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON
干扰素对人类癌基因表达的抑制
  • 批准号:
    3175180
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON
干扰素对人类癌基因表达的抑制
  • 批准号:
    6024372
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION
抑制人类癌基因表达
  • 批准号:
    3175177
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:
INHIBITION OF HUMAN ONCOGENE EXPRESSION BY INTERFERON
干扰素对人类癌基因表达的抑制
  • 批准号:
    6045146
  • 财政年份:
    1984
  • 资助金额:
    $ 9.15万
  • 项目类别:

相似海外基金

REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056554
  • 财政年份:
    1990
  • 资助金额:
    $ 9.15万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056556
  • 财政年份:
    1989
  • 资助金额:
    $ 9.15万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056555
  • 财政年份:
    1988
  • 资助金额:
    $ 9.15万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056553
  • 财政年份:
    1987
  • 资助金额:
    $ 9.15万
  • 项目类别:
The Athymic Mouse As a Model For the Study of Keloids
无胸腺小鼠作为瘢痕疙瘩研究的模型
  • 批准号:
    7816691
  • 财政年份:
    1978
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了